Original Sky Meter Intranet
Highlights
On April 22, the State Food and Drug Administration issued an announcement saying that Xueshan Gaobao Capsule and Gyxuekang Granules were approved to be converted into over-the-counter drugs. In 2023, the total sales scale of terminal gastric medicine and gynecological menstrual regulation Chinese patent medicine in retail pharmacies (urban physical pharmacies + online pharmacies) will exceed 3 billion yuan.
Source: NMPA official website
Snow Mountain Stomach Treasure Capsule is composed of 8 Chinese herbal medicines, such as long alfalfa, wood incense, papaya, hawthorn, earth wood fragrance, Nanhan water stone, strong incense rhododendron, pomegranate peel, etc., which is a classic prescription for the treatment of gastrointestinal diseases in Tibetan medicine.
According to the data of Minenet, there are currently 3 companies with production approvals for Xueshan Gaobao Capsules, including Jiangxi Yaodu Renhe Pharmaceutical, Shanxi Yiqingke Pharmaceutical, and Hefei Future Drug Development. In recent years, the terminal sales of the drug in retail pharmacies have increased year by year, maintaining a double-digit year-on-year growth rate from 2021 to 2023, and the market potential is gradually being released.
Sales trend of Xueshan Gaobao capsules in China's retail pharmacies in recent years (unit: 10,000 yuan)
Source: Minenet Grid Bureau Database
Women's Xuekang Granules is the exclusive Chinese patent medicine of Yili Pharmaceutical, which is mainly used to promote blood circulation and eliminate blood stasis, stop bleeding and regulate menstruation, and is suitable for blood stasis block, menorrhagia, excessive menstruation, postpartum lochia and other diseases.
Founded in December 2002, Yili Pharmaceutical is a pharmaceutical enterprise with pharmaceutical research and development, drug production and sales as its core business. At present, the Group has nearly 200 drug production approvals, involving a number of exclusive varieties and national protected varieties of traditional Chinese medicine, among which there are 5 gynecological menstrual regulating Chinese patent medicines that have been approved for marketing, including 3 OTC Class A (including double-span) varieties (Tianqi Dysmenorrhea Capsule, Gynxuekang Granules, Gynecologic Kangning Tablets) and 1 OTC Class B variety (Gynecological Menstrual Regulating Granules).
Yili Pharmaceutical's approved gynecological menstrual regulation Chinese patent medicine
Source: Minenet China Listed Drugs (MID) Database
Since the beginning of this year, the State Food and Drug Administration has issued at least 6 announcements on the conversion of prescription drugs to OTC drugs, with a total of 13 drugs (counted by product name), of which exclusive varieties account for more than 60%. In terms of drug types, Chinese patent medicine is the main force, occupying 12 seats, and chemical drugs account for only 1 place.
List of prescription drugs approved by the NMPA to switch to OTC drugs from 2024 to the present
Source: Minenet database, NMPA official website
Note: "Competition Pattern of Drug Terminals in China's Urban Physical Pharmacies", the statistical scope is: physical pharmacies in cities at and above the prefecture level, excluding county and rural pharmacies, and the statistical scope of "China's Online Pharmacy Terminal Competition Pattern" is: all drug data of online pharmacies in China, including all online pharmacies on third-party platforms such as Tmall and JD.com, and all online pharmacies on private domain platforms, and the above sales are calculated based on the average retail price of products in the terminal. The statistics are as of April 23, if there is any omission, please correct!